BridgeMD
Compares treatment options for Ventricular Tachycardia
Official title Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions
ClinicalTrials.gov ID: NCT06743789
What this study is testing
- What it's testing
- This is a research study that aims to understand if giving a lower dose of treatment all at once is as effective and safe as dividing it into three smaller doses for patients with a heart condition called refractory ventricular tachycardia (VT). These patients have not exhibited positive responses to conventional medications or procedures.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Age ≥ 18 years
- Structural heart disease:
- Ischemic cardiomyopathy
- Non-ischemic cardiomyopathy
- Hypertrophic cardiomyopathy
You likely can't join if
- Age \< 18 years
- Pregnancy
- Prior chest radiation therapy
See the full eligibility criteria
- Age ≥ 18 years
- Structural heart disease:
- Ischemic cardiomyopathy
- Non-ischemic cardiomyopathy
- Hypertrophic cardiomyopathy
- Refractory VT severity:
- VT leading to ICD shock with minimum 3 episodes in any 3-month period without reversible cause;
- Failed or intolerant to antiarrhythmic drug therapy (either amiodarone or ≥ 2 AADs) AND failed ablation (CA)
- OR ablation (CA) contraindicated
- Ability to understand study protocol and to write informed consent
- Willing to comply with specified pre-, post- and follow-up testing, evaluations and requirements
- Expected to remain available for at least 36 months after enrollment
- Age \< 18 years
- Pregnancy
- Prior chest radiation therapy
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.